Category: Hepatitis
Hepatitis market research reports by Global Insight Services
-
Virus-Like Particles (VLP’s) Market Analysis And Forecast To 2032: By Product Type (Hepatitis, Cancer/HPV, Gaucher Disease), Source (Yeast, Insect Cell, Plant, Others), Application (Vaccine, Therapeutics), And Region
The global Virus-Like Particles (VLP’s) Market was valued at USD 4.6 Billion in 2022 and it is anticipated to grow up to USD 8.9 Billion by 2032, at a CAGR of 6.8% during the forecast period. Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of auth ... Read More
-
Hepatitis D (HDV) - Drug Pipeline Landscape, 2023
Hepatitis D (HDV) - Drug Pipeline Landscape, 2023 Hepatitis D, also known as delta hepatitis, is an inflammation of the liver caused by the hepatitis D virus (HDV), which requires HBV for its replication. Hepatitis D infection cannot occur in the absence of hepatitis B virus. HDV-HBV co-infection is ... Read More
-
Point of Care (PoC) Molecular Diagnostics Market Analysis and Forecast to 2031: By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region
Point of Care (PoC) Molecular Diagnostics Market Analysis and Forecast to 2031: By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, H ... Read More
-
Infectious Disease Diagnostics Market Analysis and Forecast to 2031: By Product & Service (Assays, Kits & Reagents, Instruments, Services & Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next Generation Sequencing, DNA Microarray, Others), Diseases Type (Hepatitis, Human Immunodeficiency Virus, Chlamydia Trachomatis Genital Infection & Gonorrhea, Hospital Acquired Infections, Human Papillomavirus, Tuberculosis, Influenza, Others), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Others), and Region
Infectious Disease Diagnostics Market Analysis and Forecast to 2031: By Product & Service (Assays, Kits & Reagents, Instruments, Services & Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & N ... Read More
-
Hepatitis Testing/Diagnosis Market Analysis and Forecast to 2031: By Diseases Type (Hepatitis B, Hepatitis C, Others Hepatitis), Technology (ELISA, RDT, PCR, INAAT, Others), End User (Hospital & Diagnostic Laboratories, Blood Banks, Others), and Region
Hepatitis Testing/Diagnosis Market Analysis and Forecast to 2031: By Diseases Type (Hepatitis B, Hepatitis C, Others Hepatitis), Technology (ELISA, RDT, PCR, INAAT, Others), End User (Hospital & Diagnostic Laboratories, Blood Banks, Others), and Region The global hepatitis testing/diagnosis market w ... Read More
-
Vaccines Market Analysis and Forecast to 2031: By Technology Type (Recombinant & Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, & Rubella, Diphtheria, Pertussis, & Tetanus {DPT}, Polio, Hepatitis, Other Indications), and Region
Vaccines Market Analysis and Forecast to 2031: By Technology Type (Recombinant & Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Meningococcal Disease, Rotavirus, ... Read More
Research Assistance
